Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 72, 2017 - Issue 3
242
Views
2
CrossRef citations to date
0
Altmetric
Original Paper

Results from the Belgian mantle cell lymphoma registry

, , , , , , , , , , , , , , , , , , , , , , , , & show all

References

  • Vose JM. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2013Dec;88(12):1082–88.10.1002/ajh.v88.12
  • Caballero D, Campo E, López-Guillermo A, Martin A, Arranz-Saez R, Giné E, et al. Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group. Ann Hematol. 2013Sep;92(9):1151–79.10.1007/s00277-013-1783-4
  • Hoster E, Dreyling M, Klapper W, Gisselbrecht C, Van Hoof A, Kluin-Nelemans HC, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008Jan;111(2):558–65.10.1182/blood-2007-06-095331
  • Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579–86.10.1200/JCO.2006.09.2403
  • Haematological malignancies in Belgium. Brussels: Belgian Cancer Registry; 2015.
  • Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood. 2009Aug;114(8):1469–76.10.1182/blood-2009-02-179739
  • Abrahamsson A, Albertsson-Lindblad A, Brown PN, Baumgartner-Wennerholm S, Pedersen LM, D’Amore F, et al. Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study. Blood. 2014Aug;124(8):1288–95.10.1182/blood-2014-03-559930
  • Cheah CY, Seymour JF, Wang ML. Mantle cell lymphoma. J Clin Oncol. 2016Apr ;34(11):1256–69. Epub 2016 Jan 11.10.1200/JCO.2015.63.5904
  • Vergote V, Janssens A, Van Den Neste E, Verhoef G, Mourin E, André M, et al. Treatment of mantle cell lymphomas: updated recommendations of the Belgian Hematological Society 2015. Belg J Hematol. 2015;6(5):203–8.
  • Lenz G, Dreyling M, Hoster E, Wörmann B, Dührsen U, Metzner B, et al. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol. 2005Mar;23(9):1984–92.10.1200/JCO.2005.08.133

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.